Latest filing published 21 Jun 2022 for Gland Pharma Limited, €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
A Renuka Devi: trading record in brief
A Renuka Devi is a declared insider of Gland Pharma Limited (chief executive), with filings sourced from SEBI (PIT + SAST). Over a trading history stretching from 25 May 2021 to 20 June 2022, the count stands at 22 filings.
The open-market side counts 1 purchase for €38k alongside 20 sales for €599k. Netting one side against the other leaves €561k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. 2022 to date brings no purchases and 10 sales.
On 21 June 2022 came the latest disclosure, an open-market sale for €15k in Gland Pharma Limited. The last purchase on record was published on 30 May 2021, which is 1,989 days ago. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 1 day. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to A Renuka Devi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 493 shares@ ₹2,570.08922.3% of flowEquity SharesSEBI:4052c9dc58f8f214552484caf6c85df3bbe46318
- 500 shares@ ₹2,703.002.5% of flowEquity SharesSEBI:61a6fee8883be6d49411f799fc608413ba06701d
- 2,000 shares@ ₹2,736.16210.1% of flowEquity SharesSEBI:9902c52c5e754e6a770fcc73ea80f3cf5a8b0c87
- 1,500 shares@ ₹2,786.837.6% of flowEquity SharesSEBI:4926003f304e21aaec225415f91d86b12bd6dd09
- 500 shares@ ₹2,818.672.5% of flowEquity SharesSEBI:c8deb44f8f331ec0a87d6715b8715bc97a1323b8
- 500 shares@ ₹2,905.7962.6% of flowEquity SharesSEBI:fd38be5906584cbc40c566d83a488441fcbe008e
- 1,000 shares@ ₹2,790.815.0% of flowEquity SharesSEBI:b2de7ba50a1a0f3c4facef4d01ff79b7285a85b7
- 4,500 shares@ ₹542.004.5% of flowEquity SharesSEBI:3b87b2b152557a601cb676514908ade1371176f1
- 700 shares@ ₹3,286.464.1% of flowEquity SharesSEBI:6dbad3b7fb05036d1ba5fc258f5bcb32bd9db836
- 1,200 shares@ ₹3,244.66677.0% of flowEquity SharesSEBI:c95234a02cb23a1da48b78f875d1a194c425b637
- 200 shares@ ₹3,298.001.2% of flowEquity SharesSEBI:aa1d957b9ce8e75539b75e20132171b8c7dcbe1e
- 100 shares@ ₹3,948.000.7% of flowEquity SharesSEBI:a1eac1225a92743be6c6305b3a7fdc6a8932b68a
- 500 shares@ ₹3,685.263.2% of flowEquity SharesSEBI:e8ad462942aedc0ed899460335ace4a7cb152e36
- 500 shares@ ₹3,635.463.2% of flowEquity SharesSEBI:241a96509258b7151a8e27a82ce869df096f777a
- 500 shares@ ₹3,625.503.2% of flowEquity SharesSEBI:f862253526aaa851d8b38c6f8fc9c05854710e1a
- 1,000 shares@ ₹3,630.486.4% of flowEquity SharesSEBI:39c6caa1e23289d12a52f30172231a2bdb719158
- 2,250 shares@ ₹3,583.333314.2% of flowEquity SharesSEBI:e12e95b04dec4d7496b50e1d924c6e457d1b5545
- 1,000 shares@ ₹3,240.920.0008% mcap5.5% of flowEquity SharesSEBI:d3cd3c4197eeabd113eccf746fd95faf8dcb6dd4
- 1,000 shares@ ₹3,340.525.6% of flowEquity SharesSEBI:b9709379ce01cd7bcf98b9130e105c8baf1e8c5dCanonical exit: 26 Aug 2021 (T+90)
- 797 shares@ ₹3,320.000.0007% mcap4.5% of flowEquity SharesSEBI:85234e973f5644fc786017ba9c4569bf4b307b50
- 750 shares@ ₹3,220.000.0006% mcap4.1% of flowEquity SharesSEBI:e6458d918aa00cc975e4894f321a55ba134feadf
- 10 shares@ ₹3,200.000.0000% mcap0.1% of flowEquity SharesSEBI:9259619745d8ab9fb81b221463d285a56f2b1e5e
22 of 22 declarations